Stanford University
Showing 2,181-2,200 of 2,219 Results
-
Roham Zamanian
Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly Interests1. Development and evaluation of prognostic and diagnostic integral biomarkers in PAH.
2. Prevalence and Treatment of Insulin Resistance in PAH.
3. Role of inflammation and proteomic signature in PAH
4. Development of novel therapeutics (bench to bedside) including FK506 & Elastase Inhibition in PAH.
5. Assessment of Vasoreactivity (gain and loss) in pulmonary arterial hypertension
6. Assessment of microvascular function in PAH. -
Astrid Nicole Zamora
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
BioDr. Astrid N. Zamora is a public health researcher and epidemiologist. Her work has utilized robust birth cohort data to examine associations between diet and environmental pollutants with sleep and metabolic health outcomes among adolescents and midlife women.
Following her Master of Public Health degree at UC Berkeley School of Public Health, Dr. Zamora completed her PhD at the University of Michigan School of Public Health. As a doctoral trainee at Michigan, her dissertation research, funded by a Research Supplement to Promote Diversity in Health-Related Research from NIH/NIEHS, focused on examining the interplay between exposure to endocrine-disrupting chemicals, sleep, and metabolic health risk among pubertal adolescents and peri-menopausal women from Mexico City.
As a current NHLBI T32 postdoctoral research fellow at Stanford University School of Medicine, Dr. Zamora is receiving training in RCT study design and citizen science methods, learning how to bridge her training in epidemiology with community-based research approaches, thereby ensuring that her research agenda maintains a meaningful connection to the community and its real-world context. The goal of her current research, bolstered by her previous and ongoing training, is to explore the interconnections between diet, the built environment, and physical activity. She is particularly focused on understanding how these factors relate to psychosocial and cardiometabolic health amongst Latinx communities across the life course. -
James L. Zehnder, M.D.
Professor of Pathology (Research) and of Medicine (Hematology)
Current Research and Scholarly InterestsMy main research and clinical interests include molecular pathogenesis of acquired cytopenias, genetic testing for inherited non-malignant hematologic disorders, next-generation sequencing approaches to T and B cell clonality testing, somatic mutations in cancer and assessment of minimal residual disease in cancer patients.
-
Huaiyu Zhang
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Zhang obtained her MS in Neuroscience from the University of Southern California and earned her PhD in Clinical Psychology from Emory University. She completed both her predoctoral internship and postdoctoral fellowship at Emory University School of Medicine. Prior to joining Stanford in 2023, Dr. Zhang supported survivors of interpersonal violence at the University of California San Francisco Trauma Recovery Center for over seven years. Dr. Zhang embraces an integrative, contextualized, evidence-informed, and strength-based approach to teaching, supervision, and clinical care. She provides services in English and Mandarin.
-
Tian Yi Zhang, MD, PhD
Assistant Professor of Medicine (Hematology)
BioDr. Zhang is a board-certified hematologist. She is also an assistant professor of hematology at Stanford University School of Medicine. In addition to her medical degree, she holds a PhD in cellular and molecular immunology.
In her clinical practice, she treats patients with all forms of hematological malignancies, offering specialized expertise in acute myeloid leukemia, including therapy-resistant cases. For each patient, she develops a personalized care plan encompassing novel treatment options.
Her research activities include conducting early phase clinical trials, investigator initiated clinical trials (IITs), studying the immune repertoire in patients with myeloid malignancies, and exploring cholesterol metabolic dependencies of acute myeloid leukemia (AML).
She was the recipient of an A.P. Giannini Foundation fellowship award, which supports innovative research. The award helped fund Dr. Zhang’s study of how AML cells interact with other cells in bone marrow. A significant finding confirmed that AML cells secrete a protein that suppresses the production of red blood cells, the same protein that causes inflammation in disorders such as rheumatoid arthritis and Crohn’s disease.
Her many other honors include the National Cancer Institute Career Development (K08) Award, the American Society of Hematology (ASH) Research Training Award for Fellows, Stanford Cancer Institute - American Cancer Society (SCI-ACS) Pilot Grant and Best ASH Abstract Award two years in a row. She also has earned recognition from the National Institutes of Health and American College of Physicians.
She has published her research findings on topics such as advanced therapy for high-risk myelodysplastic syndromes and reversal of bone marrow failure induced by AML. Her work has appeared in Leukemia & Lymphoma, Science Translational Medicine, Cancer Research, the Journal of Clinical Investigation, Journal of Immunology, and elsewhere.
Dr. Zhang is a member of the American Association of Cancer Research and American Society of Hematology. She advises and mentors Stanford medical students, residents and fellows. She delivers invited lectures to faculty and fellows. In addition, she has been an invited speaker on the topic of acute myeloid leukemia at the Association of Northern California Oncologists Update on Hematological Malignancies.
